EquityZen Growth Technology Fund LLC - Series 1180
Raised
$5M
Investors
81
Min Invest
$10,017
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1180 is a Delaware pooled investment fund that raised $5.3M from 81 investors with a $10K minimum investment, filed March 28, 2022. The offering claimed exemptions under Rule 506(b) and Section 3(c)(1). This is part of the EquityZen platform, which operates approximately 1,889 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption structure typical of private secondaries platforms, with a $10K minimum enabling retail accredited investor participation. The 81-investor count and $5.3M raise yield an average commitment of approximately $65K, consistent with democratized access to late-stage private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
